Literature DB >> 9605617

Maternal weight differences do not explain ethnic differences in biochemical screening.

P K Bryant-Greenwood1, J E O'Brien, X Huang, Y Yaron, M Ayoub, M P Johnson, M I Evans.   

Abstract

In previous work, we and others have shown that serum levels of alpha-fetoprotein, human chorionic gonadotropin, and estriol vary among the four commonly defined racial/ethnic groups seen in the United States: white, African-American, Asian, and Hispanic. We have suggested that better sensitivity and specificity could improve screening sensitivity and specificity. However, it has been argued that systematic weight differences among the groups could explain the variation. We evaluated the results from 208,257 patients having screening and found systematic weight differences. However, these differences were not as large as the racial/ethnic differences, showing that weight does not fully explain the discrepancy, and, therefore, four separate data bases give more accurate results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605617     DOI: 10.1159/000020801

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

1.  Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.

Authors:  Savitree Pranpanus; Ounjai Kor-Anantakul; Thitima Suntharasaj; Chitkasaem Suwanrath; Tharangrut Hanprasertpong; Ninlapa Pruksanusak; Chusana Petpichetchian; Manaphat Suksai; Natthicha Chainarong; Rapphon Sawaddisan
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  Korean-specific parameter models for calculating the risk of Down syndrome in the second trimester of pregnancy.

Authors:  Ji Young Kwon; In Yang Park; Yong Gue Park; Young Lee; Guisera Lee; Jong Chul Shin
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

3.  A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.

Authors:  Agnès Marchio; Stéphane Bertani; Teresa Rojas Rojas; Franco Doimi; Benoît Terris; Eric Deharo; Anne Dejean; Eloy Ruiz; Pascal Pineau
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

4.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

5.  Ethnicity-Specific Normative Models of Quadruple Test as a Screening Test for Down Syndrome.

Authors:  Praetip Praikaew; Kuntharee Traisrisilp; Chanane Wanapirak; Ratanaporn Sekararithi; Theera Tongsong
Journal:  Medicina (Kaunas)       Date:  2021-06-24       Impact factor: 2.430

6.  Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study.

Authors:  Rakchanok Boonpiam; Chanane Wanapirak; Supatra Sirichotiyakul; Ratanaporn Sekararithi; Kuntharee Traisrisilp; Theera Tongsong
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-15       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.